CTOs on the Move


 
PAVmed (NASDAQ: PAVM) is a highly-differentiated, multi-product medical device company employing a unique and proven business model designed to advance products from concept to commercialization much more rapidly and with significantly less capital than the typical medical device company. This model enables us to pursue an expanding pipeline strategy with a view to enhancing and accelerating value creation.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.pavmed.com
  • One Grand Central Place Suite 4600
    New York, NY USA 10165
  • Phone: 212.949.4319

Executives

Name Title Contact Details
Sunny Webb
Chief Technology Officer and Vice President of Data and Analytics Profile

Similar Companies

Myerson The Tooth Company

Myerson The Tooth Company is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Katalyst Surgical

Katalyst Surgical is the industry leader in ophthalmic surgical instruments. Our experienced team has over 40 years of design, manufacturing, and quality control of ophthalmic surgical products. It is our goal to provide superior service paired with high quality ophthalmic products at a cost saving to our customers. We stand by our company-wide policy that the customer is always right... By continually gathering customer feedback and working with our highly skilled professional team, Katalyst Surgical continues to deliver unmatched ophthalmic instruments while increasing our number of loyal customers. Katalyst Surgical is a premier research and development facility... Keeping up with cutting edge products and the changing industry has allowed us to serve our customers with 100% satisfaction Superior products within your budget... Your business is important to our team at Katalyst Surgical. Our goal is to offer superior products with premium customer service within your budget. Committed to our customers... We greatly appreciate your feedback on our ophthalmic surgical instruments and repair services.

Viz

In 2015, five seminal randomized controlled trials were published in the neurovascular space demonstrating endovascular thrombectomy to be the new gold standard for treating large vessel occlusion strokes. During that same year, advancements in artificial intelligence and deep learning made it possible to analyze medical imaging rapidly and accurately. However, despite having proven effective interventions for stroke, most stroke patients were getting treatment late or not at all. At Stanford University, Dr. Chris Mansi (neurosurgeon) and Dr. David Golan (machine learning researcher) identified this problem and together they sought to change it.

ROX Medical

ROX MEDICAL is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Alpha Omega Instrument

Alpha Omega Instrument Corp. is a Cumberland, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.